Search

everythinglearnresearchcommunity

for

Search:↓

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Using finasteride with TIP extends time off period for prostate cancer patients.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Finasteride is effective for hair loss but has controversial side effects.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Minoxidil can reduce functions related to androgen receptors.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Finasteride effectively reduces prostate size and lowers surgery risk in men with benign prostatic hyperplasia.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Adherence to finasteride treatment for prostate issues is generally low.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Dutasteride effectively treats hair loss and prostate issues.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.